Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the transaction mentioned ....

August 06, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Prior Intimation for Board Meeting of ANLON HEALTHCARE LIMITED Respected Sir/Madam, With reference to above captioned Subject and in Compliance with Regulation 29 and 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, this is to inform you that the Meeting of the Board of Directors of the Anlon Healthcare Limited (“Company”) is scheduled to be held on Tuesday, August 11, 2026, at the registered office of the company, inter alia, to consider and approve the following businesses: 1. To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the Financial Year ended 31st March 2026 together with the reports of the Board of Directors and Auditors thereon. 2. To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the Financial Year ended 31st March 2026 together with the reports of the Board of Directors and Auditors thereon. 3. To appoint a director in place of Mr. Punitkumar Rameshbhai Rasadia (Din: 06696258) who retires by rotation and being eligible, offers himself for re- appointment. 4. To Regularize Mr. Kishan Vinodkumar Raja (DIN: 11522235) as a Non-Executive & Independent Director. 5. To Appointment of Internal Auditor. 6. To Approve remuneration of Cost Auditor of the Company. 7. To Approve and consider enhancement of authorized share capital. 8. To approve and consider alteration of capital clause contained in the Memorandum of Association. 9. To approve and consider borrowing money (ies) for the purpose of Business of the Company. 10. To approve and consider creation of security on the properties of the Company, both present and future, in favour of lenders. 11. To approve and consider inter-corporate investment & loans 12. To approve, adopt, and consider approval for issuance of equity shares of the Company on preferential basis for consideration other than cash to the Shareholders of Apiqo Organics Private Limited and Bizotic Lifescience Private Limited, in lieu of acquisition of their shares held in Apiqo Organics Private Limited and Bizotic Lifescience Private Limited 13. To approve and consider Material Related Party Transactions Between Apiqo Organics Private Limited And the Company ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in 14. To approve and consider Material Related Party Transactions Between Bizotic Lifescience Private Limited And the Company 15. To approve and consider Material Related Party Transactions Between Remember India Health Links Private Limited And the Company 16. To Fixing of the day, date, time, and venue for holding the Annual General Meeting. 17. To fix the date of Book Closure for Share transfer and Register of Members. 18. To approve the draft Notice convening the Annual General Meeting. 19. For Appointment of Scrutinizers for e-voting facility for Annual General Meeting of the Company. 20. Any other business(s) with permission of Chair, if any. You are requested to take the above information on your record Thanking You. Yours Faithfully, FOR, ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: L24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in